Yüklüyor......
Low calcium dialysate combined with CaCO(3) in hyperphosphatemia in hemodialysis patients
This aim of this study was to observe the effects of the application of low calcium dialysate (LCD) combined with oral administration of CaCO(3) in the treatment of hyperphosphatemia, as well as blood Ca(2+), calcium-phosphate product (CPP), parathyroid hormone (PTH) and blood pressure in patients u...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3702715/ https://ncbi.nlm.nih.gov/pubmed/23837063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2013.1067 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|